Association of Hepatitis C Virus With Alcohol Use Among U.S. Adults: NHANES 2003–2010


      Excessive alcohol use exacerbates morbidity and mortality among hepatitis C virus (HCV)–infected people. The purpose of this study was to describe self-reported patterns of alcohol use and examine the association with HCV infection and other sociodemographic and health-related factors.


      Data from 20,042 participants in the 2003–2010 National Health and Nutrition Examination Survey were analyzed in 2014. Estimates were derived for self-reported demographic characteristics, HCV-RNA (indicative of current HCV infection) status, and alcohol use at four levels: lifetime abstainers, former drinkers, non-excessive current drinkers, and excessive current drinkers.


      Former drinkers and excessive current drinkers had a higher prevalence of HCV infection (2.2% and 1.5%, respectively) than never or non-excessive current drinkers (0.4% and 0.9%, respectively). HCV-infected adults were estimated to ever drink five or more drinks/day almost every day at some time during their lifetime about 3.3 times more often (43.8% vs 13.7%, p<0.001) than those who were never infected with HCV. Controlling for age, sex, race/ethnicity, education, and having a usual source of health care, HCV infection was significantly associated with excessive current drinking (adjusted prevalence ratio, 1.3; 95% CI=1.1, 1.6) and former drinking (adjusted prevalence ratio, 1.3; 95% CI=1.1, 1.6).


      Chronic HCV infection is associated with both former and excessive current drinking. Public health HCV strategies should implement interventions with emphasis on alcohol abuse, which negatively impacts disease progression for HCV-infected individuals.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Bouchery E.E.
        • Harwood H.J.
        • Sacks J.J.
        • Simon C.J.
        • Brewer R.D.
        Economic costs of excessive alcohol consumption in the U.S., 2006.
        Am J Prev Med. 2011; 41: 516-524
        • Stahre M.
        • Roeber J.
        • Kanny D.
        • Brewer R.D.
        • Zhang X.
        Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States.
        Prev Chronic Dis. 2014; 11: E109
        • Denniston M.M.
        • Jiles R.B.
        • Drobeniuc J.
        • et al.
        Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010.
        Ann Intern Med. 2014; 160: 293-300
        • Ly K.N.
        • Xing J.
        • Klevens R.M.
        • Jiles R.B.
        • Holmberg S.D.
        Causes of death and characteristics of decedents with viral hepatitis, United States, 2010.
        Clin Infect Dis. 2014; 58: 40-49
        • Mahajan R.
        • Xing J.
        • Liu S.J.
        • et al.
        Mortality among persons in care with hepatitis C virus infection: the Chronic Hepatitis Cohort Study (CHeCS), 2006–2010.
        Clin Infect Dis. 2014; 58: 1055-1061
        • Kanwal F.
        • Hoang T.
        • Kramer J.R.
        • et al.
        Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection.
        Gastroenterology. 2011; 140: 1182-1188
        • Shaw J.J.
        • Shah S.A.
        Rising incidence and demographics of hepatocellular carcinoma in the USA: what does it mean?.
        Expert Rev Gastroenterol Hepatol. 2011; 5: 365-370
        • McHutchison J.G.
        • Bacon B.R.
        Chronic hepatitis C: an age wave of disease burden.
        Am J Manag Care. 2005; 11: S286-S295
        • Rein D.B.
        • Wittenborn J.S.
        • Weinbaum C.M.
        • Sabin M.
        • Smith B.D.
        • Lesesne S.B.
        Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States.
        Dig Liver Dis. 2011; 43: 66-72
        • Freeman Jr, R.B.
        • Steffick D.E.
        • Guidinger M.K.
        • Farmer D.G.
        • Berg C.L.
        • Merion R.M.
        Liver and intestine transplantation in the United States, 1997-2006.
        Am J Transplant. 2008; 8: 958-976
        • McMahon B.J.
        • Bruden D.
        • Bruce M.G.
        • et al.
        Adverse outcomes in Alaska natives who recovered from or have chronic hepatitis C infection.
        Gastroenterology. 2010; 138: 922-931
        • Younossi Z.M.
        • Zheng L.
        • Stepanova M.
        • Venkatesan C.
        • Mir H.M.
        Moderate, excessive or heavy alcohol consumption: each is significantly associated with increased mortality in patients with chronic hepatitis C.
        Aliment Pharmacol Ther. 2013; 37: 703-709
        • Smith B.D.
        • Morgan R.L.
        • Beckett G.A.
        • Falck-Ytter Y.
        • Holtzman D.
        • Ward J.W.
        Hepatitis C virus testing of persons born during 1945-1965: recommendations from the Centers for Disease Control and Prevention.
        Ann Intern Med. 2012; 157: 817-822
        • Bruix J.
        • Barrera J.M.
        • Calvet X.
        • et al.
        Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis.
        Lancet. 1989; 2: 1004-1006
        • Stoller E.P.
        • Hund A.J.
        • Webster N.J.
        • et al.
        Alcohol consumption within the context of hepatitis C: a qualitative study of non-problematic drinkers.
        Alcohol Alcohol. 2006; 41: 546-552
      1. National Health and Nutrition Examination Survey. Questionnaires, datasets, and related documentation. Centers for Disease Control and Prevention website. Accessed March 27, 2016.

        • Tsai J.
        • Ford E.S.
        • Li C.
        • Zhao G.
        Past and current alcohol consumption patterns and elevations in serum hepatic enzymes among U.S. adults.
        Addict Behav. 2012; 37: 78-84
      2. National Health and Nutrition Examination Survey. 2009–2010 Lab methods. Centers for Disease Control and Prevention website. Accessed March 27, 2016.

      3. U.S. Census Bureau. Poverty main. Accessed March 27, 2016.

        • Poynard T.
        • Bedossa P.
        • Opolon P.
        Natural history of liver fibrosis progression in patients with chronic hepatitis C.
        Lancet. 1997; 349: 825-832
        • Tsui J.I.
        • Pletcher M.J.
        • Vittinghoff E.
        • Seal K.
        • Gonzales R.
        Hepatitis C and hospital outcomes in patients admitted with alcohol-related problems.
        J Hepatol. 2006; 44: 262-266
        • Ghany M.G.
        • Strader D.B.
        • Thomas D.L.
        • Seeff L.B.
        Diagnosis, management, and treatment of hepatitis C: an update.
        Hepatology. 2009; 49: 1335-1374
        • Ward J.W.
        Hepatitis C virus: the 25-year journey from discovery to cure.
        Hepatology. 2014; 60: 1479-1482
        • Anand B.S.
        • Currie S.
        • Dieperink E.
        • et al.
        Alcohol use and treatment of hepatitis C virus: results of a national multicenter study.
        Gastroenterology. 2006; 130: 1607-1616
        • Dore G.J.
        • Ward J.
        • Thursz M.
        Hepatitis C disease burden and strategies to manage the burden (Guest Editors Mark Thursz, Gregory Dore and John Ward).
        J Viral Hepat. 2014; 21: 1-4
        • Everhart J.E.
        Alcohol and hepatitis C: do we have a drinking problem?.
        Gastroenterology. 2006; 130: 1912-1914
        • U.S. Department of Agriculture, U.S. Department of Health and Human Services
        Dietary Guidelines for Americans 2010.
        7th edition. U.S. Government Printing Office, Washington, DC2010
        • Denniston M.M.
        • Klevens R.M.
        • McQuillan G.M.
        • Jiles R.B.
        Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001–2008.
        Hepatology. 2012; 55: 1652-1661
        • Dieperink E.
        • Fuller B.
        • Isenhart C.
        • et al.
        Efficacy of motivational enhancement therapy on alcohol use disorders in patients with chronic hepatitis C: a randomized controlled trial.
        Addiction. 2014; 109: 1869-1877
        • U.S. Preventive Services Task Force
        Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: recommendation statement.
        Ann Intern Med. 2004; 140: 554-556
        • Edlin B.R.
        • Eckhardt B.J.
        • Shu M.A.
        • Holmberg S.D.
        • Swan T.
        Toward a more accurate estimate of the prevalence of hepatitis C in the United States.
        Hepatology. 2015; 62: 1353-1363
        • Tseng F.C.
        • O’Brien T.R.
        • Zhang M.
        • et al.
        Seroprevalence of hepatitis C virus and hepatitis B virus among San Francisco injection drug users, 1998 to 2000.
        Hepatology. 2007; 46: 666-671
        • Edlin B.R.
        Perspective: test and treat this silent killer.
        Nature. 2011; 474: S18-S19

      CHORUS Manuscript

      View Open Manuscript